Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABT-510 in Refractory Lymphoma
NCT00061672Phase 2Completed
- Sponsor
- Abbott Laboratories
- Start
- Apr 2003
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of abt-510 in non-Hodgkin lymphoma (NHL), Hodgkin lymphoma (HL), sponsored by Abbott Laboratories. Started Apr 2003; status: completed.
02
Drugs
abt-510
03
Conditions
non-Hodgkin lymphoma (NHL)Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00061672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00061672.